The Modern Urologist

Go Beyond Gleason for Prostate Cancer Treatment Decisions

February 22, 2024 Myriad Genetics

Send us a text

On this episode of TMU we're diving deep into the rapidly evolving landscape of prostate cancer diagnosis and treatment with special guest, Dr. Adam Cole, a board-certified pathologist. Dr. Cole will discuss the traditional Gleason grading system, the limitations of pathology, and how incorporating genetic markers can improve patient outcomes.